Dr Katarzyna Owczarczyk, Consultant in Clinical Oncology
Dr Katarzyna Owczarczyk
Consultant in Clinical Oncology
Dr Katarzyna Owczarczyk MD (res) MRCP FRCR
Consultant in Clinical Oncology
Dr Katarzyna Owczarczyk
Consultant in Clinical Oncology MD (res) MRCP FRCR
Areas of expertise
- Biliary cancer
- Gastrointestinal cancers
- Liver cancer
- Oesophageal cancer
- Oligometastic disease
About Dr Katarzyna Owczarczyk
GMC number: 7062724
Year qualified: 2006
Place of primary qualification: Universitat Köln
Dr Kasia Owczarczyk is a consultant in clinical oncology specialising in gastro-oesophageal, rectal, and hepatobiliary cancers. She currently works at Guy's and St Thomas' NHS Foundation Trust.
Dr Owczarczyk trained in clinical oncology at University College Hospital London and Mount Vernon Cancer Centre. She has completed a research MD, a post-doctoral fellowship at Genentech in South San Francisco, and a clinical fellowship in cancer imaging at King's College London.
In 2018, Dr Owczarczyk was appointed as an honorary senior clinical lecturer at King's College London. She was awarded the Guy's Cancer Career Development and Innovation Award in 2019. Her research has been published in prestigious journals such as Science TM, JCI Insights, and Radiotherapy Oncology.
Dr Owczarczyk’s areas of expertise include chemoradiotherapy and radiotherapy treatment of gastro-oesophageal and rectal cancers, chemoradiotherapy treatment of pancreatic cancer, and stereotactic body radiotherapy (SBRT), including MRI-guided SBRT. She is also skilled in intraluminal HDR brachytherapy for oesophageal cancer, predictive markers, and radionics.
Her professional interests focus on advancing treatment methodologies and improving patient outcomes in her specialised fields.
Areas of expertise
- Biliary cancer
- Chemoradiotherapy and radiotherapy treatment of gastro-oesophageal cancer
- Chemoradiotherapy and radiotherapy treatment of rectal cancer
- Chemoradiotherapy treatment of pancreatic cancer
- Chemotherapy
- Gastrointestinal cancers
- Intraluminal HDR brachytherapy of oesophageal cancer
- Liver cancer
- Oesophageal cancer
- Oligometastic disease
- Pancreatic cancer
- Predictive markers
- Radiomics
- Radiotherapy
- Rectal cancer
- Stereotactic ablative radiotherapy (SABR)
- Stereotactic body radiotherapy (SBRT) including MRI guided SBRT